Clinical evaluation of multiple sclerosis:: quantification by use of scales

被引:6
|
作者
Izquierdo, G [1 ]
Ruiz-Peña, JL [1 ]
机构
[1] Hop Univ Virgen Macarena, Serv Neurol, Unidad Esclerosis, E-41009 Seville, Spain
关键词
clinical evaluation; cognitive impairment; EDSS; fatigue; multiple sclerosis; functional composite; scales;
D O I
10.33588/rn.3602.2002350
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Clinical evaluation is indispensable in multiple sclerosis (MS)for the quantitative measurement of the extent of the disorder, which is in turn required to find out how the disease is evolving and the influence the different forms of treatment are having on it, both in the experimental phase and in the usual monitoring they are subjected to. Method We review the different scales that are used to evaluate the distinct symptomatic and functional aspects of MS and the repercussions these have on the extent of disability displayed in the patient's social and personal life. Although in recent years, the EDSS has been an essential, irreplaceable scale in MS, other instruments of measurement that complement it have also begun to appear. The fatigue, cognitive function and quality of life scales are being used more and more frequently. The Multiple Sclerosis Functional Composite is an instrument that is used more and more frequently in MS and has proved to be highly sensitive in the evaluation of very important clinical trials. Conclusions. The lack of correlation between the distinct scales corroborates the fact that they measure complementary aspects of MS.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [21] Fatigue in multiple sclerosis:: a comparison of different rating scales and correlation to clinical parameters
    Flachenecker, P
    Kümpfel, T
    Kallmann, B
    Gottschalk, M
    Grauer, O
    Rieckmann, P
    Trenkwalder, C
    Toyka, K
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (06) : 523 - 526
  • [22] Comparative analysis of two clinical scales for multiple sclerosis: review of 302 cases
    Felipe, E
    Mendes, MF
    Moreira, MA
    Tilbery, CP
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (2A) : 300 - 303
  • [23] The Use of Evoked Potentials in Multiple Sclerosis Clinical Trials
    Skeen, Mark B.
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2021, 38 (03) : 161 - 161
  • [24] Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
    Notcutt, William G.
    NEUROTHERAPEUTICS, 2015, 12 (04) : 769 - 777
  • [25] Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
    William G. Notcutt
    Neurotherapeutics, 2015, 12 : 769 - 777
  • [26] Modified EDSS for Use in Multiple Sclerosis Clinical Practice
    Baldassari, Laura
    Longbrake, Erin
    Cross, Anne
    Salter, Amber
    Naismith, Robert
    NEUROLOGY, 2016, 86
  • [27] Clinical and videonystagmographical evaluation of vestibular manifestations in multiple sclerosis
    El Alaoui El Rhoul, S.
    Ridal, M.
    Ouattassi, N.
    Bouchal, S.
    El Amine El Alami, M.
    Belahssen, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 524 - 524
  • [28] Clinical evaluation and follow-up in multiple sclerosis
    Roullet, E
    REVUE NEUROLOGIQUE, 2001, 157 (8-9) : 1121 - 1123
  • [29] CLINICAL EVALUATION OF POSSIBLE ETIOLOGIC FACTORS IN MULTIPLE SCLEROSIS
    ALTER, M
    SPEER, J
    NEUROLOGY, 1968, 18 (02) : 109 - &
  • [30] Unsupervised quantification of tissue immunofluorescence in animal models of multiple sclerosis - Instructions for use
    Stolz, Leonie
    Derouiche, Amin
    Weber, Frank
    Foerch, Christian
    Brunkhorst, Robert
    JOURNAL OF NEUROSCIENCE METHODS, 2019, 320 : 87 - 97